PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2020-06-08

Date Title Company
08-Jun-2020 Innovent and Roche Enter into A Strategic Collaboration to Discover and Develop Multiple Products including Cellular Therapies and Bispecific Antibodies Innovent Biologics, Inc.
08-Jun-2020 Arena Pharmaceuticals Announces R&D Leadership Transition Arena Pharmaceuticals, Inc.
08-Jun-2020 Kindred Biosciences Announces Plan to Strengthen its Strategic Position Kindred Biosciences, Inc.
08-Jun-2020 Ardelyx Appoints Veteran Biopharma Executive, Justin Renz, as Chief Financial Officer Ardelyx
08-Jun-2020 CSL Behring to Acquire Biotech Company Vitaeris CSL Behring
08-Jun-2020 WORLD EQUINE PHARMACEUTICALS AND SUPPLEMENTS MARKET RESEARCH REPORT 2025, COVID BUSINESS IMPACT INFORMATION COVERED The Holistic Reports
08-Jun-2020 Federal Government Announces New Pilot Program to Help Stop Illegal Availability of Unapproved Opioids Online U.S. Food and Drug Administration
08-Jun-2020 Neurana Pharmaceuticals Announces First Patient Enrolled in CNS Effects Clinical Study Neurana Pharmaceuticals, Inc.
08-Jun-2020 A2A Pharmaceuticals Collaborates With LAXAI Life Sciences to Co-develop SARS-CoV-2 Main Proteases Inhibitors for the Treatment of COVID-19 LAXAI Life Sciences
08-Jun-2020 AstraZeneca to lead workshop at Wearable Injectors and Connected Devices Conference 2020 SMi Group Ltd
08-Jun-2020 Press Launch of hVIVO COVID Clear Test, the most accurate antibody test available to UK employers to help get people back to work hVIVO
08-Jun-2020 UCB Shares Breadth of Innovative New Data from Rheumatology Portfolio for EULAR 2020 E-Congress UCB
08-Jun-2020 AbbVie at EULAR - RINVOQ™ (upadacitinib) Meets Primary and Key Secondary Endpoints in Phase 3 Head-to-Head Study Versus ORENCIA (abatacept) in Rheumatoid Arthritis Patients AbbVie
08-Jun-2020 Sanofi to present Phase 3 results of avalglucosidase alfa in patients with late-onset Pompe disease Sanofi
08-Jun-2020 US FDA Grants Mexiletine Orphan Drug Designation Lupin Limited
08-Jun-2020 STRATEC'S ANNUAL GENERAL MEETING APPROVES DISTRIBUTION OF A DIVIDEND OF € 0.84 PER SHARE STRATEC SE
08-Jun-2020 US FDA Grants Mexiletine Orphan Drug Designation Lupin
08-Jun-2020 Oxford Biomedica Signs Five Year Collaboration Agreement with the Vaccines Manufacturing and Innovation Centre Oxford Biomedica plc
08-Jun-2020 Oxford Biomedica Signs Five Year Collaboration Agreement with the Vaccines Manufacturing and Innovation Centre Oxford Biomedica
08-Jun-2020 Achilles Therapeutics to set up manufacturing operations at the CGT Catapult manufacturing centre Achilles Therapeutics